Navigation Links
Micromet, Inc. Reports First Quarter 2009 Financial Results
Date:5/6/2009

se 2 clinical trial with its human anti-EpCAM IgG1 antibody adecatumumab (MT201). This randomized, controlled phase 2 trial will evaluate adecatumumab in the treatment of patients with colorectal cancer after complete resection of liver metastases.

  • On April 2, Micromet announced the filing of a clinical trial application in Europe by its partner Nycomed for the anti-GM-CSF antibody MT203. The filing triggered a milestone payment to Micromet of approximately $2.0 million.

"We are very pleased with our accomplishments during the first quarter of 2009, and we look forward to presenting clinical data at the American Society of Clinical Oncology meeting and the European Hematology Society meeting in the second quarter," stated Christian Itin, President and CEO of Micromet, Inc.

Financial Results:

Quarter Ended March 31, 2009

For the three months ended March 31, 2009, Micromet recognized total revenues of $7.5 million, compared to $5.9 million for the same period in 2008. Total operating expenses were $12.4 million for the three months ended March 31, 2009, compared to $13.3 million for the same period in 2008.

Loss from operations for the three months ended March 31, 2009 was $4.9 million, compared to a loss from operations of $7.3 million for the same period in 2008.

For the three months ended March 31, 2009, Micromet reported a net loss of $0.3 million, or a loss of $0.01 per basic and diluted common share, compared to a net loss of $5.9 million, or $0.14 per basic and diluted common share, for the same period in 2008. The net loss for the three months ending March 31, 2009 includes a non-cash gain of $4.4 million, reflecting a decrease during the quarter in the fair value of warrants issued in connection with a private placement transaction in 200
'/>"/>

SOURCE Micromet, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine news :

1. Micromet, Inc. Reports First Quarter 2008 Financial Results
2. Micromet, Inc. Reports Second Quarter 2008 Financial Results
3. Micromet, Inc. to Host Webcast and Conference Call to Discuss Blinatumomab Data Presented at American Society of Hematology Annual Meeting
4. New Study Reports High Injury Rates for Hotel Workers, Even Higher Rates for Women and Nonwhites
5. Haemacure Reports Third Quarter 2007 Results
6. First-Ever List of the 5,000 Fastest-Growing Businesses Reports Total Revenue of $194.5 Billion
7. Consumer Reports Analysis: Drugs for Nerve Pain, Fibromyalgia Effective, But Not Always Best
8. MDS Reports Third Quarter 2007 Results
9. Allied Healthcare Reports Strong Fourth Quarter, Flat Net Income for Fiscal 2007 vs. 2006
10. AtriCure Reports First Human Implant of the Cosgrove-Gillinov Left Atrial Appendage Occlusion System
11. NMHC Reports Fourth Quarter and Fiscal Year 2007 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/23/2014)... healthy, unrelated donors was safe and effective in ... Clostridium difficile , according to a new ... and available online. Known as fecal microbiota ... via a colonoscope or a nasogastric tube. The ... treatment more readily available to patients. , A ...
(Date:4/23/2014)... to give exercise enthusiasts the extra nudge they need ... a cyber buddy can help. , The study, which ... is the first to indicate that although a human ... software-generated partner also can be effective. , "We wanted ... motivate people to give greater effort while exercising than ...
(Date:4/23/2014)... an important brain receptor has a dramatic effect against ... a University at Buffalo animal study has found. , ... a novel lead compound for treating cocaine addiction, for ... published as an online preview article in Neuropsychopharmacology ... RO5263397, severely blunted a broad range of cocaine addiction ...
(Date:4/23/2014)... American Gastroenterological Association (AGA) Research Foundation is pleased ... AGA Research Scholar Awards program, launched in 1984, ... research careers in digestive diseases. This year, the ... allowing for three consecutive years of funding. , ... are paving the way for promising research developments ...
(Date:4/23/2014)... A team of scientists led by a researcher from ... the National University of Singapore has identified the cancer ... opens up the possibility of developing new drugs for ... cancers. , The research group, led by Dr Chan ... for the first time that a cancer-specific variant of ...
Breaking Medicine News(10 mins):Health News:Pilot study suggests ways to widen access to fecal transplants for C. diff infections 2Health News:Cyber buddy is better than 'no buddy' 2Health News:Novel compound halts cocaine addiction and relapse behaviors 2Health News:AGA announces 2014 Class of AGA Research Scholars 2Health News:Scientists identify cancer specific cell for potential treatment of gastric cancer 2Health News:Scientists identify cancer specific cell for potential treatment of gastric cancer 3
... the Albert Einstein College of Medicine in Yeshiva University ... to use radioactivity as an energy source for ... to Dr. Arturo Casadevall, chair of microbiology and immunology ... finding could trigger a recalculation of the Earth's energy ...
... currently gripping humanity, Cuban President Fidel Castro called for governments ... arms. ,The non-profit exercise of medicine is ... recent article broadcast Tuesday by the island's mass media. ... "wonderful submarine" in Great Britain, which can shoot down lethal ...
... Australian High Commissioner to India, John McCarthy, has announced ... Meghalaya, Manipur and Mizoram. ,The ... be implemented by the UN Office on Drugs and ... High Commission release said. ,The Australian ...
... A new study has found that combination asthma ... quality of life (HRQL) and greater patient-reported satisfaction ... or formoterol or placebo). ,SYMBICORT is ... long-term maintenance treatment of asthma in patients 12 ...
... new imaging technique - magnetic resonance elastography (MRE) - is ... ,The studies were conducted by a team ... ,As part of one study, researchers conducted MRE examinations ... volunteers. ,The researchers found that MRE accurately ...
... have to leave physical bumps and bruises to ... environment. Behavior that intentionally harms another individual, ... aggression), is just as significant a concern for ... Dr. Sara Goldstein from Montclair State University and ...
Cached Medicine News:Health News:Astronauts can Now Feed on 'radiation-eating' Fungi 2Health News:Australia Contributes Additional Funds for HIV Prevention in North-East 2Health News:Combo Therapy may Be Highly Beneficial in Asthma Control 2Health News:Psychological Bullying Hits Just as Hard 2
(Date:1/14/2014)... Dynamic Healthcare Services, Inc. ("DHS"), a portfolio company of GMH ... Medical Equipment, Inc. ("Progressive") of Clarion, PA ... were not disclosed. Progressive is a full ... of sleep, mobility, and respiratory products to customers in the ...
(Date:1/14/2014)... , Jan. 14, 2014 Animal Emergency Critical Care, a LifeCentre ... Leesburg, Virginia is the first in Loudoun ... Dr. Susan M. Barnes , Medical Director, ... and husband, Dr. Cole Taylor , are avid scuba divers. ...
(Date:1/14/2014)... , Jan. 14, 2014 NineSigma , ... hold its Innovation Leadership Summit , May 14-16, ... Cleveland Ohio . ... and organizations committed to breakthrough achievements through open innovation. ...
Breaking Medicine Technology:Dynamic Healthcare Services Completes Progressive Home Medical Equipment of Clarion, PA Investment 2Dynamic Healthcare Services Completes Progressive Home Medical Equipment of Clarion, PA Investment 3Hyperbaric Veterinary Medicine (hvm) Announces Animal Emergency Critical Care Installs A Small Animal Hyperbaric Chamber 2Expect the Unexpected from Leading Global Innovators at NineSigma Leadership Summit, Sharing Winning Strategies to Advance Innovation 2Expect the Unexpected from Leading Global Innovators at NineSigma Leadership Summit, Sharing Winning Strategies to Advance Innovation 3Expect the Unexpected from Leading Global Innovators at NineSigma Leadership Summit, Sharing Winning Strategies to Advance Innovation 4
... , VIENNA, Va., Jan. 11 CEL-SCI Corporation ... a developer of vaccines and therapeutics for the prevention and ... validation of all critical utilities and manufacturing equipment at its ... represents a very important milestone as it allows CEL-SCI to ...
... SANTA MONICA, Calif., Jan. 11 Derycz Scientific (OTC Bulletin Board: ... the flow of information from content publishers to enterprise customers and ... 2010, on the website of DDN ( Drug Discovery ... Peter Derycz, is titled "Speeding the Path to FDA Approval in ...
Cached Medicine Technology:CEL-SCI Completes Validation of Manufacturing Facility Allowing It To Commence Manufacturing of Multikine 2CEL-SCI Completes Validation of Manufacturing Facility Allowing It To Commence Manufacturing of Multikine 3CEL-SCI Completes Validation of Manufacturing Facility Allowing It To Commence Manufacturing of Multikine 4Derycz Scientific Featured In DDN (Drug Discovery News) 2Derycz Scientific Featured In DDN (Drug Discovery News) 3
... workhorse for the lab, featuring easy-to-use control knobs, ... Product features , , Digital display with ... (W x D) footprint fits on a crowded ... 24-place capacity , Brushless motor provides maintenance-free ...
... and Proteomic users should inquire about ... Preparation capability for run-to-run replication. Compact ... accommodates 4x750 ml up to 4550xg ... throughput screening, research and patient specimen ...
Inquire...
... Oven/Shaker rigidly controls the temperature and ... hybridization and washing steps. This facilitates ... nucleic acids and proteins immobilized on ... radioactive and nonradioactive labeling systems supplied ...
Medicine Products: